1h Free Analyst Time
The publisher has been monitoring the coronary artery bypass grafting market and it is poised to grow by $34.01 mn during 2022-2026, progressing at a CAGR of 5% during the forecast period. The report on the coronary artery bypass grafting market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of CVDs, growing medical tourism in developing economies, and a growing number of cardiovascular surgeries.
The coronary artery bypass grafting market analysis includes product type segment and geographic landscape.
The coronary artery bypass grafting market is segmented as below:
By Product Type
- On-Pump
- Off-Pump
- Minimally Invasive Surgery
By Geographical Landscape
- North America
- Europe
- APAC
- Rest of World (ROW)
This study identifies the increasing geriatric population as one of the prime reasons driving the coronary artery bypass grafting market growth during the next few years. Also, the development of mitral valve restoration systems using tissue engineering, and high R&D investments and M&A activities will lead to sizable demand in the market.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The report on the coronary artery bypass grafting market covers the following areas:
- Coronary artery bypass grafting market sizing
- Coronary artery bypass grafting market forecast
- Coronary artery bypass grafting market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronary artery bypass grafting market vendors that include Abbott Laboratories, Aesculap Inc., AtriCure Inc., Aruga Technologies, Bentley InnoMed GmbH, BIOTRONIK SE and Co KG, Boston Scientific Corp., Artivion Inc., Genesee BioMedical Inc., Getinge AB, Johnson and Johnson Inc., KARL STORZ SE and Co. KG, KLS Martin Group, Medtronic Plc, Saphena Medical Inc., Scanlan International Inc., Stryker Corp., Terumo Corp., VasoPrep Surgical, Cook Medical LLC, and Teleflex Inc. Also, the coronary artery bypass grafting market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher announces the Publication of its Research Report - Global Coronary Artery Bypass Grafting Market 2022-2026The publisher recognizes the following companies as the key players in the global coronary artery bypass grafting market: Abbott Laboratories, Aesculap Inc., AtriCure Inc., Aruga Technologies, Bentley InnoMed GmbH, BIOTRONIK SE and Co KG, Boston Scientific Corp., Artivion Inc., Genesee BioMedical Inc., Getinge AB, Johnson and Johnson Inc., KARL STORZ SE and Co. KG, KLS Martin Group, Medtronic Plc, Saphena Medical Inc., Scanlan International Inc., Stryker Corp., Terumo Corp., VasoPrep Surgical, Cook Medical LLC, and Teleflex Inc.
Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is increasing geriatric population.'
According to the report, one of the major drivers for this market is the increasing prevalence of CVDs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Aesculap Inc.
- AtriCure Inc.
- Aruga Technologies
- Bentley InnoMed GmbH
- BIOTRONIK SE and Co KG
- Boston Scientific Corp.
- Artivion Inc.
- Genesee BioMedical Inc.
- Getinge AB
- Johnson and Johnson Inc.
- KARL STORZ SE and Co. KG
- KLS Martin Group
- Medtronic Plc
- Saphena Medical Inc.
- Scanlan International Inc.
- Stryker Corp.
- Terumo Corp.
- VasoPrep Surgical
- Cook Medical LLC
- Teleflex Inc.
